Cargando…
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential
Neoepitopes or neoantigens are a spectrum of unique mutations presented in a particular patient’s tumor. Neoepitope-based adoptive therapies have the potential of tumor eradication without undue damaging effect on normal tissues. In this context, methods based on the T cell receptor (TCR) engineerin...
Autores principales: | Poorebrahim, Mansour, Mohammadkhani, Niloufar, Mahmoudi, Reza, Gholizadeh, Monireh, Fakhr, Elham, Cid-Arregui, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203496/ https://www.ncbi.nlm.nih.gov/pubmed/33654227 http://dx.doi.org/10.1038/s41417-021-00307-7 |
Ejemplares similares
-
Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”
por: Teppert, Karin, et al.
Publicado: (2022) -
Counteracting CAR T cell dysfunction
por: Poorebrahim, Mansour, et al.
Publicado: (2021) -
The Enigmatic Nature of the TCR-pMHC Interaction: Implications for CAR-T and TCR-T Engineering
por: Shevyrev, D. V., et al.
Publicado: (2022) -
TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens
por: Akatsuka, Yoshiki
Publicado: (2020) -
CAR NK-92 cell–mediated depletion of residual TCR(+) cells for ultrapure allogeneic TCR-deleted CAR T-cell products
por: Kath, Jonas, et al.
Publicado: (2023)